CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-13 | Lee Kevin Chief Executive Officer | Sale | −11,194 | $34.00 | $381K | 251,219 |
| 2021-07-13 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −35,446 | 377,162 | ||
| 2021-07-12 | Crockett Nigel Chief Business Officer | Option exercise | +4,331 | $11.66 | $50K | 4,331 |
| 2021-07-12 | Crockett Nigel Chief Business Officer | Option exercise | +1,723 | $9.82 | $17K | 6,054 |
| 2021-07-12 | Crockett Nigel Chief Business Officer | Option exercise | +974 | $15.36 | $15K | 7,028 |
| 2021-07-12 | Crockett Nigel Chief Business Officer | Sale | −7,028 | $32.03 | $225K | 0 |
| 2021-07-12 | Crockett Nigel Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −4,331 | 103,086 | ||
| 2021-07-12 | Crockett Nigel Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −1,723 | 58,006 | ||
| 2021-07-12 | Crockett Nigel Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −974 | 43,783 | ||
| 2021-07-12 | Lee Kevin Chief Executive Officer | Option exercise | +1,936 | $14.00 | $27K | 256,670 |
| 2021-07-12 | Lee Kevin Chief Executive Officer | Sale | −1,936 | $32.04 | $62K | 254,734 |
| 2021-07-12 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −1,936 | 412,608 | ||
| 2021-07-06 | Crockett Nigel Chief Business Officer | Option exercise | +271 | $9.82 | $3K | 271 |
| 2021-07-06 | Crockett Nigel Chief Business Officer | Sale | −271 | $32.00 | $9K | 0 |
| 2021-07-06 | Crockett Nigel Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −271 | 59,729 | ||
| 2021-05-07 | Lee Kevin Chief Executive Officer | Option exercise | +5,604 | $14.00 | $78K | 260,338 |
| 2021-05-07 | Lee Kevin Chief Executive Officer | Sale | −5,604 | $32.23 | $181K | 254,734 |
| 2021-05-07 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −5,604 | 414,544 | ||
| 2021-05-06 | Lee Kevin Chief Executive Officer | Option exercise | +1,716 | $14.00 | $24K | 256,450 |
| 2021-05-06 | Lee Kevin Chief Executive Officer | Sale | −1,716 | $32.14 | $55K | 254,734 |
Page 23 of 26 · 520 trades